Gene · 4065
Papers1,798
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,798
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Evaluation of the Mechanisms of Galacto-Oligosaccharide (GOS)-Induced IgE Cross-Linking on Basophils in GOS Allergy. | Front Allergy | 2022 | 35386657 | PubTator, text mining | PubMed |
| CD90 Marks a Mesenchymal Program in Human Thymic Epithelial Cells In Vitro and In Vivo. | Front Immunol | 2022 | 35371075 | PubTator, text mining | PubMed |
| Ablation of Cbl-b and c-Cbl in dendritic cells causes spontaneous liver cirrhosis via altering multiple properties of CD103+ cDC1s. | Cell Death Discov | 2022 | 35354799 | PubTator, text mining | PubMed |
| Development of Peptide-Based Vaccines for Cancer. | J Oncol | 2022 | 35342400 | PubTator, text mining | PubMed |
| Delivery of mRNA for regulating functions of immune cells. | J Control Release | 2022 | 35337940 | PubTator, text mining | PubMed |
| Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases. | Viruses | 2022 | 35336927 | PubTator, text mining | PubMed |
| Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products Be Helpful? | Molecules | 2022 | 35335319 | PubTator, text mining | PubMed |
| Increasing Role of Targeted Immunotherapies in the Treatment of AML. | Int J Mol Sci | 2022 | 35328721 | PubTator, text mining | PubMed |
| STxB as an Antigen Delivery Tool for Mucosal Vaccination. | Toxins (Basel) | 2022 | 35324699 | PubTator, text mining | PubMed |
| Combined Single Cell Transcriptome and Surface Epitope Profiling Identifies Potential Biomarkers of Psoriatic Arthritis and Facilitates Diagnosis via Machine Learning. | Front Immunol | 2022 | 35309349 | PubTator, text mining | PubMed |
| Coordinated changes in glycosylation regulate the germinal center through CD22. | Cell Rep | 2022 | 35294874 | PubTator, text mining | PubMed |
| The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation. | J Immunother Cancer | 2022 | 35292514 | PubTator, text mining | PubMed |
| Biomarkers for Breast Adenocarcinoma Using In Silico Approaches. | Evid Based Complement Alternat Med | 2022 | 35280505 | PubTator, text mining | PubMed |
| Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity. | J Immunother Cancer | 2022 | 35256516 | PubTator, text mining | PubMed |
| Regulation of biomaterial implantation-induced fibrin deposition to immunological functions of dendritic cells. | Mater Today Bio | 2022 | 35252832 | PubTator, text mining | PubMed |
| Haemagglutinin antigen selectively targeted to chicken CD83 overcomes interference from maternally derived antibodies in chickens. | NPJ Vaccines | 2022 | 35241682 | PubTator, text mining | PubMed |
| A Rare Co-Occurrence of Triple Mutations in JAK2, CALR, and MPL in the Same Patient with Myelofibrosis. | Case Rep Hematol | 2022 | 35237453 | PubTator, text mining | PubMed |
| Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia. | Exp Hematol Oncol | 2022 | 35236415 | PubTator, text mining | PubMed |
| Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo. | Antibodies (Basel) | 2022 | 35225867 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. | Pharmaceutics | 2022 | 35214155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4065/papers?page=15